Latest News

Screening all donated blood for Zika virus is not cost-effective in the United States




Universal screening of individual blood donations for Zika virus, which began in 2016, was not cost-effective in the 50 states during the first year. Widespread screening would only be cost-effective in the high mosquito season in Puerto Rico and never in the 50 states. Findings from a microsimulation study are published in Annals of Internal Medicine.

Source link




Related posts

Bristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial

Newsemia

Bad Info May Be Scaring Patients Away From Statins

Newsemia

Opioid Addicts Turning to Unapproved Antidepressant

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy